UPLOAD Filing
TriSalus Life Sciences, Inc.
Date: May 5, 2025 · CIK: 0001826667 · Accession: 0000000000-25-004736
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286797
Letter
Re: TriSalus Life Sciences, Inc. Registration Statement on Form S-3 Filed April 28, 2025 File No. 333-286797 Dear Mary Szela:
May 5, 2025
Mary Szela Chief Executive Officer TriSalus Life Sciences, Inc. 6272 W. 91st Ave. Westminster, Colorado 80031
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Conlon Danberg at 202-551-4466 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Carlos Ramirez, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 5, 2025 Mary Szela Chief Executive Officer TriSalus Life Sciences, Inc. 6272 W. 91st Ave. Westminster, Colorado 80031 Re: TriSalus Life Sciences, Inc. Registration Statement on Form S-3 Filed April 28, 2025 File No. 333-286797 Dear Mary Szela: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Carlos Ramirez, Esq. </TEXT> </DOCUMENT>